Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety.
about
Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiologyAdult Onset Still's Disease Associated with Mycoplasma pneumoniae Infection and Hemophagocytic Lymphohistiocytosis.Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.Cardiovascular disease in patients with autoinflammatory syndromes.Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease
P2860
Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@ast
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@en
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@nl
type
label
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@ast
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@en
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@nl
prefLabel
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@ast
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@en
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@nl
P2093
P2860
P356
P1476
Interleukin 1 inhibition with ...... is of its efficacy and safety.
@en
P2093
Dongsheng Hong
Shuyin Han
Xingguang Liang
Xingguo Zhang
Zhihai Yang
P2860
P304
P356
10.2147/DDDT.S73428
P407
P5008
P577
2014-11-25T00:00:00Z